Skip to content
Company Analysis

IM Cannabis Corp. IMCC

A comprehensive view of key metrics, scores, and financial health for IM Cannabis Corp.

Overview of IM Cannabis Corp.

IMCC NCM
Healthcare Drug Manufacturers - Specialty & Generic Framework: Pharma / Mature Biotech Micro Cap
IM Cannabis Corp. (IMCC), is a Micro Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $0.75, about 5162.7% undervalued vs fair value, -98.1% 1Y return, ranked 1104/1145 in sector.
Metrics Rev Growth 1.3% ROE -516.3% Gross Margin 17.7% Div Yield 0.00%
USD 0.75
-5.31%
(Delayed)
• Vol 90d: 212.1%
Market Cap
$1.23M
Enterprise Value
$10.99M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Fair
Health
Weak
Efficiency
Weak
Valuation
Weak
Growth
Weak
Profitability
Fair
Health
Weak
Efficiency
Weak
Valuation
Weak
Completeness: 100%
Confidence: 98%
Updated: Oct 31
Top Beats

Quick Facts

Website https://imcannabis.com
HQ Tel Aviv
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$35
$39
$44
Current: $0.75 +5163% vs base

Engine Room Money Flow™

Micro Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
CAD 54.7M
1.3%%
Gross Profit
CAD 9.7M
14.6%%
R&D Expense
CAD 11.0K
Operating Income (EBIT)
-CAD 8.9M
13.5%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

R&D Intensity
0.0%
Fair

Lower R&D intensity - may indicate mature portfolio or cost cuts

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
1
Active Leaks
1/1
Improving
0
High Impact
1
Critical
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating IM Cannabis Corp.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
38
/100
Developing
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Operating Leverage in Effect Operating leverage is evident (score 0.71), with margins expanding over time.

Key risks

  • ROIC Below WACC or Peers ROIC at 18.3th percentile suggests inefficient capital deployment.
  • Liquidity Concerns Liquidity is concerning (score 0.10), raising questions about short-term obligations.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
28
Premium

Signals, strengths and risks for Pricing Power

Premium

Signals, strengths and risks for Cost Advantage

Premium

Signals, strengths and risks for Customer Stickiness

Premium

Signals, strengths and risks for Capital Efficiency

Premium

Signals, strengths and risks for Resilience

Premium

Signals, strengths and risks for Scale & Market Position

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

vs Industry Peers 83% Coverage
Trade-Off Triangle Visualization A ternary plot showing IMCC's balance between Growth (38.1%), Profitability (28.8%), and Safety (33.1%). Growth 38% Safety 33% Profitability 29%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

40th percentile vs peers
40
Key Signals
Rev Growth YoY 1.3% 41p Revenue CAGR 3Y 0.2% 38p EPS Growth YoY 40.8% 45p TSR -40.4% 27p
Strengths
  • Cash Flow to Debt Ratio in top 20% of peers (4.10, 90th percentile)
Risks
  • Growth below peer median (percentile: 40)

Profitability

30th percentile vs peers
30
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

34th percentile vs peers
35
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for IM Cannabis Corp..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$39.47
- - -
+5162.7% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000